ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104 | +60.0% | 9,126 | +44.3% | 0.00% | – |
| Q2 2023 | $65 | -30.1% | 6,325 | -47.6% | 0.00% | – |
| Q1 2023 | $93 | +106.7% | 12,079 | +98.7% | 0.00% | – |
| Q4 2022 | $45 | -99.1% | 6,080 | +818.4% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 662 | -15.5% | 0.00% | – |
| Q2 2022 | $7,000 | -58.8% | 783 | -58.5% | 0.00% | – |
| Q1 2022 | $17,000 | -95.7% | 1,886 | -93.3% | 0.00% | – |
| Q4 2021 | $392,000 | +668.6% | 28,196 | +494.0% | 0.00% | – |
| Q3 2021 | $51,000 | +292.3% | 4,747 | +223.1% | 0.00% | – |
| Q2 2021 | $13,000 | -91.3% | 1,469 | -89.6% | 0.00% | – |
| Q1 2021 | $150,000 | +500.0% | 14,105 | +405.0% | 0.00% | – |
| Q3 2020 | $25,000 | – | 2,793 | +139550.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 2 | -98.5% | 0.00% | – |
| Q1 2018 | $1,000 | – | 134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $27,257,000 | 2.19% |
| Omega Fund Management, LLC | 1,284,900 | $13,620,000 | 1.29% |
| Samsara BioCapital, LLC | 399,190 | $4,231,000 | 0.78% |
| Soleus Capital Management, L.P. | 313,064 | $3,318,000 | 0.60% |
| Avidity Partners Management LP | 1,511,000 | $16,017,000 | 0.44% |
| Dorsey Wright & Associates | 3,380 | $35,828,000 | 0.42% |
| EcoR1 Capital, LLC | 741,290 | $7,858,000 | 0.35% |
| Orbimed Advisors | 3,070,955 | $32,552,000 | 0.30% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,460,000 | 0.29% |
| DAFNA Capital Management LLC | 113,302 | $1,201,000 | 0.28% |